Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Molecular taxonomy of myelodysplastic syndromes and its clinical implications

Elsa Bernard, Robert P. Hasserjian, Peter L. Greenberg, Juan E. Arango Ossa, Maria Creignou, Heinz Tuechler, Jesus Gutierrez-Abril, Dylan Domenico, Juan S. Medina-Martinez, Max Levine, Konstantinos Liosis, Noushin Farnoud, Maria Sirenko, Martin Jädersten, Ulrich Germing, Guillermo Sanz, Arjan A. van de Loosdrecht, Yasuhito Nannya, Olivier Kosmider, Matilde Y. Follo, Felicitas Thol, Lurdes Zamora, Ronald F. Pinheiro, Andrea Pellagatti, Harold K. Elias, Detlef Haase, Christina Ganster, Lionel Ades, Magnus Tobiasson, Laura Palomo, Matteo Giovanni Della Porta, Pierre Fenaux, Monika Belickova, Michael R. Savona, Virginia M. Klimek, Fabio P. S. Santos, Jacqueline Boultwood, Ioannis Kotsianidis, Valeria Santini, Francesc Solé, Uwe Platzbecker, Michael Heuser, Peter Valent, Carlo Finelli, Maria Teresa Voso, Lee-Yung Shih, Michaela Fontenay, Joop H. Jansen, José Cervera, Norbert Gattermann, Benjamin L. Ebert, Rafael Bejar, Luca Malcovati, Seishi Ogawa, Mario Cazzola, Eva Hellström-Lindberg, Elli Papaemmanuil

Blood (2024) 144 (15): 1617–1632.

https://doi.org/10.1182/blood.2023023727

Published: 2024

Includes: Supplemental data

Journal Articles

Diagnostic Utility of Comprehensive RNA-Seq Analysis in Adult B-ALL

Noushin Farnoud, Konstantinos Liosis, Daniel Leongamornlert, Jesús Gutiérrez-Abril, Juan E. Arango Ossa, Gunes Gundem, Anu Amallraja, Dylan Domenico, Joseph McCarter, Amy A Kirkwood, Laura Clifton-Hadley, Bela Patel Wrench, Anthony Moorman, Adele Kay Fielding, Elli Papaemmanuil

Blood (2023) 142 (Supplement 1): 1601.

https://doi.org/10.1182/blood-2023-190519

Published: 2023

Journal Articles

A D e Novo Supernumerary Ring Chromosome 1 Causes B-Cell Acute Lymphoblastic Leukemia in Monozygotic Twins Due to Independent and Partially Convergent Evolutionary Trajectories

Jesús Gutiérrez-Abril, Gunes Gundem, Elise Fiala, Konstantinos Liosis, Noushin Farnoud, Daniel Leongamornlert, Anu Amallraja, Juan E. Arango Ossa, Dylan Domenico, Max F. Levine, Juan Santiago Medina Martinez, Michael F. Walsh, Sylwia Jasinski, Andrew L. Kung, Neerav N. Shukla, William L. Carroll, Elli Papaemmanuil

Blood (2023) 142 (Supplement 1): 4352.

https://doi.org/10.1182/blood-2023-181194

Published: 2023

Journal Articles

Mutational Profile of Children with Myeloproliferative Neoplasms

Kayleigh Rutherford, Noushin Farnoud, Aishwarya Krishnan, Raajit K Rampal, Ross L. Levine, Nicole Kucine

Blood (2022) 140 (Supplement 1): 3991–3992.

https://doi.org/10.1182/blood-2022-164732

Published: 2022

Journal Articles

Long-Term Outcome of Patients with Follicular Lymphoma Is Not Fundamentally Affected By KMT2D , EZH2, and Crebbp Mutational Status

Kurt S. Bantilan, Kayleigh Rutherford, Joseph McCarter, Noushin Farnoud, Juan E. Arango-Ossa, Elli Papaemmanuil, Andrew D. Zelenetz

Blood (2022) 140 (Supplement 1): 3635–3637.

https://doi.org/10.1182/blood-2022-170205

Published: 2022

Journal Articles

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

Blood (2022) 139 (19): 2931–2941.

https://doi.org/10.1182/blood.2021012743

Published: 2022

Includes: Supplemental data

Journal Articles

Treatment of Myelofibrosis Patients with the TGF-β 1/3 Inhibitor AVID200 (MPN-RC 118) Induces a Profound Effect on Platelet Production

Blood (2021) 138 (Supplement 1): 142.

https://doi.org/10.1182/blood-2021-148995

Published: 2021

Journal Articles

Molecular Predictors and Effectiveness of Measurable Residual Disease (MRD) Eradication with Chemotherapy and Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Blood (2020) 136 (Supplement 1): 18–20.

https://doi.org/10.1182/blood-2020-137552

Published: 2020

Journal Articles

Clonal Hematopoiesis and Its Implications for Flow Cytometric Assessment of Measurable Residual Disease in Patients with NPM1- mutated Acute Myeloid Leukemia

Sanam Loghavi, MD, Courtney D. DiNardo, MD MSCE, Koichi Takahashi, MD PhD, Rashmi Kanagal-Shamanna, MD, Tomoyuki Tanaka, MDPhD, Ken Furudate, DDM, PhD, Nicholas J. Short, MD, Tapan M. Kadia, MD, Marina Konopleva, MD PhD, Noushin Farnoud, PhD, Sherry A. Pierce, BSN, BA, Joseph D. Khoury, MD, Jeffrey L. Jorgensen, MD PhD, Keyur P. Patel, MBBS, PhD, L. Jeffrey Medeiros, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MBBS, Sa A Wang, MD

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-139871

Published: 2020

Journal Articles

Landscape of TP53 Mutations in MPN

Noushin Farnoud, PhD, Christopher Famulare, MS, Elli Papaemmanuil, PhD, Erin McGovern, BA, Juan Medina, MS, Juan E. Arango Ossa, BS, Raajit K. Rampal, MD PhD, Bing Li, MD, Ross L. Levine, MD, John Mascarenhas, MD, Rona Singer Weinberg, PhD, Minal A Patel, MPH, Ronald Hoffman, MD

Blood (2019) 134 (Supplement_1): 1681.

https://doi.org/10.1182/blood-2019-132014

Published: 2019

Journal Articles

The Genetic Architecture of Myeloproliferative Neoplasms-Blast Phase (MPN-BP) Stem Cells

Xiaoli Wang, MD PhD, Raajit K. Rampal, MD PhD, Cing Siang Hu, Noushin Farnoud, PhD, Christopher Famulare, MS, Minal A Patel, MPH, Erin McGovern, BA, Ronald Hoffman, MD

Blood (2019) 134 (Supplement_1): 1677.

https://doi.org/10.1182/blood-2019-128836

Published: 2019

Journal Articles

Significance of Abnormalities of PPM1D in Myeloproliferative Neoplasms

Bridget Marcellino, MD PhD, Joseph Tripodi, Michal Bar-Natan, MD, Harry Fruchtman, Noushin Farnoud, PhD, Min Lu, PhD, Heidi E. Kosiorek, MS, Amylou C. Dueck, PhD, Raajit K. Rampal, MD PhD, John Mascarenhas, MD, Vesna Najfeld, PhD, Ronald Hoffman, MD

Blood (2019) 134 (Supplement_1): 4207.

https://doi.org/10.1182/blood-2019-129565

Published: 2019

Journal Articles

Expansion of Prior Existing TP53 Mutated Clones in Polycythemia Vera Patients Treated with Idasanutlin

Bridget Marcellino, MD PhD, Bruno Cassinat, PharmD, PhD, Noushin Farnoud, PhD, Min Lu, PhD, Emmanuelle Verger, PhD, Erin McGovern, BA, Minal A Patel, MPH, Heidi E. Kosiorek, MS, Meenakshi Mehrotra, PhD, Jane Houldsworth, PhD, Amylou C. Dueck, PhD, Michael Rossi, PhD, Jean-Jacques Kiladjian, MD PhD, Raajit K. Rampal, MD PhD, John Mascarenhas, MD, Ronald Hoffman, MD

Blood (2019) 134 (Supplement_1): 838.

https://doi.org/10.1182/blood-2019-128342

Published: 2019

Journal Articles

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

Blood (2019) 134 (18): 1498–1509.

https://doi.org/10.1182/blood.2019000428

Published: 2019

Includes: Supplemental data

Journal Articles

Oral idasanutlin in patients with polycythemia vera

John Mascarenhas, Min Lu, Heidi Kosiorek, Elizabeth Virtgaym, Lijuan Xia, Lonette Sandy, Ruben Mesa, Bruce Petersen, Noushin Farnoud, Vesna Najfeld, Raajit Rampal, Amylou Dueck, Ronald Hoffman

Blood (2019) 134 (6): 525–533.

https://doi.org/10.1182/blood.2018893545

Published: 2019

Includes: Supplemental data

Journal Articles

Alisertib (MLN8237), an Oral Selective Inhibitor of Aurora Kinase a, Has Clinical Activity and Restores GATA1 Expression in Patients with Myelofibrosis

Blood (2018) 132 (Supplement 1): 688.

https://doi.org/10.1182/blood-2018-99-110381

Published: 2018

Journal Articles

TP53 Mutations Predict Poorer Responses to CPX-351 in Acute Myeloid Leukemia

Aaron D Goldberg, MD PhD, Chetasi Talati, MD, Pinkal Desai, MD MPH, Christopher Famulare, MS, Sean M Devlin, PhD, Noushin Farnoud, PhD, David A Sallman, MD, Jeffrey E. Lancet, MD, Gail J. Roboz, MD, Kendra L. Sweet, MD, Martin S. Tallman, MD

Blood (2018) 132 (Supplement 1): 1433.

https://doi.org/10.1182/blood-2018-99-117772

Published: 2018

Journal Articles

Molecular Predictors and Current Management of Minimal Residual Disease (MRD) Following Induction Chemotherapy for Acute Myeloid Leukemia (AML)

Blood (2018) 132 (Supplement 1): 292.

https://doi.org/10.1182/blood-2018-99-112938

Published: 2018

Journal Articles

Early Detection and Molecular Characterization of Therapy-Related Leukemia in Children Reveals Patterns of Disease Transformation and Guides Future Surveillance Protocols

Barbara Spitzer, MD, Gunes Gundem, PhD, Noushin Farnoud, PhD, Nathan Millard, MD, Erin McGovern, BA, Minal Patel, BA, Max Levine, MS, Juan Medina, MS, Yangyu Zhou, BS, Juan E. Arango Ossa, BS, Michael Francis Walsh, MD, Ross L. Levine, MD, Irene Y. Cheung, ScD, Scott A. Armstrong, MD PhD, Nai-Kong V. Cheung, MD PhD, Elli Papaemmanuil, PhD

Blood (2018) 132 (Supplement 1): 291.

https://doi.org/10.1182/blood-2018-99-120005

Published: 2018

Journal Articles

Myeloproliferative Neoplasm (MPN) Blastic Transformation Occurs at the Level of Hematopoietic Stem Cells

Xiaoli Wang, PhD, Cing Siang Hu, Joseph Tripodi, Vesna Najfeld, PhD, Bruce Petersen, MD, Raajit K. Rampal, MD PhD, Noushin Farnoud, Christopher Famulare, MS, John Mascarenhas, MD, Ronald Hoffman, MD

Blood (2018) 132 (Supplement 1): 101.

https://doi.org/10.1182/blood-2018-99-117348

Published: 2018

NARROW

Molecular taxonomy of myelodysplastic syndromes and its clinical implications

Diagnostic Utility of Comprehensive RNA-Seq Analysis in Adult B-ALL

A D e Novo Supernumerary Ring Chromosome 1 Causes B-Cell Acute Lymphoblastic Leukemia in Monozygotic Twins Due to Independent and Partially Convergent Evolutionary Trajectories

Mutational Profile of Children with Myeloproliferative Neoplasms

Long-Term Outcome of Patients with Follicular Lymphoma Is Not Fundamentally Affected By KMT2D , EZH2, and Crebbp Mutational Status

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

Treatment of Myelofibrosis Patients with the TGF-β 1/3 Inhibitor AVID200 (MPN-RC 118) Induces a Profound Effect on Platelet Production

Molecular Predictors and Effectiveness of Measurable Residual Disease (MRD) Eradication with Chemotherapy and Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Clonal Hematopoiesis and Its Implications for Flow Cytometric Assessment of Measurable Residual Disease in Patients with NPM1- mutated Acute Myeloid Leukemia

Landscape of TP53 Mutations in MPN

The Genetic Architecture of Myeloproliferative Neoplasms-Blast Phase (MPN-BP) Stem Cells

Significance of Abnormalities of PPM1D in Myeloproliferative Neoplasms

Expansion of Prior Existing TP53 Mutated Clones in Polycythemia Vera Patients Treated with Idasanutlin

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

Oral idasanutlin in patients with polycythemia vera

Alisertib (MLN8237), an Oral Selective Inhibitor of Aurora Kinase a, Has Clinical Activity and Restores GATA1 Expression in Patients with Myelofibrosis

TP53 Mutations Predict Poorer Responses to CPX-351 in Acute Myeloid Leukemia

Molecular Predictors and Current Management of Minimal Residual Disease (MRD) Following Induction Chemotherapy for Acute Myeloid Leukemia (AML)

Early Detection and Molecular Characterization of Therapy-Related Leukemia in Children Reveals Patterns of Disease Transformation and Guides Future Surveillance Protocols

Myeloproliferative Neoplasm (MPN) Blastic Transformation Occurs at the Level of Hematopoietic Stem Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only